We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Comparison of Primary Care and Traditional Internal Medicine Residents

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00224224
First Posted: September 22, 2005
Last Update Posted: April 3, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Weill Medical College of Cornell University
  Purpose
The goal of this study is to identify objective differences between primary care and traditional medicine residents in clinical performance, continuity of care and utilization of resources. Specifically, this retrospective study will analyze the database collected by CLIMACS, the computer system at Cornell Internal Medicine Associates (CIMA). This system is used for clinical and administrative purposes; it manages and tracks patient's information and demographics, appointment booking, clinical diagnosis, prescriptions and medications, laboratory and radiology test, and consults. In our study, we will analyze a subset of the CLIMACS database from previous years.

Condition
Breast Cancer Screening Cervical Cancer Screening Cholesterol Screening Asthma Admission Rate Diabetes Management

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: A Comparison of Primary Care and Traditional Internal Medicine Residents

Further study details as provided by Weill Medical College of Cornell University:

Primary Outcome Measures:
  • To identify the differences between primary care and traditional medicine residents in clinical performance, continuity of care and utilization of resources.

Study Start Date: January 1995
Estimated Study Completion Date: January 2005
Detailed Description:

Three areas will be examined:

  1. Clinical performance
  2. Continuity of care
  3. Utilization of resources

Clinical performance will be assessed using Health Plan Employer data and Information Set (HEDIS) performance standards. These standards were developed for the purposes of quality assessment, and in our study we will examine the following HEDIS standards:

  1. Breast Cancer Screening- the proportion of women between the ages of 52 and 64 who have had a mammogram within a two year period.
  2. Cervical Cancer Screening- the proportion of women between the ages of 21 and 64 who had a Pap test in the preceding 3 years.
  3. Cholesterol Screening- the proportion of patients ages 20 to 39 and 40-59 who have had their cholesterol tested at least once in the past five years.
  4. Asthma admission rate- the proportion of asthmatics admitted to the hospital for the care of asthma per year.
  5. Diabetic Standards-

    1. Admission for cellulitis/ 1000 diabetics per year.
    2. Admission for diabetes/ 1000 diabetics per year.
    3. Inpatient days per 100 diabetics per year.
    4. Prevalence of ischemic heart disease.
    5. Prevalence of severe renal disease.
    6. Diabetics with >2 hemoglobin A1C drawn per year.

Continuity of Care will be assessed by 3 different indicators:

  1. The proportion of visits that are made to the designated primary care provider of the number of visits made.
  2. The proportion of missed appointments of the total number of appointments.
  3. The proportion of walk in visits of the total number of appointments.

Resource utilization will be assessed by examining the following:

  1. Number of lab test per year per patient.
  2. Number of specialty consults per year per patient.
  3. Hospital admission rates per patient per year.
  4. Cost to medications. Confidentiality will be maintained throughout the study. In clinical practice access to CLIMACS is limited to the medical providers and administrators by individuals access codes. Furthermore, our study will remove specific identifiers to maintain the anonymity of both the patients and residents.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years to 64 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Patients who are followed as outpatients by a Cornell affiliated internist at the Cornell Internal Medicine Associates (CIMA).
  2. Patients at New York Hospital who may or may not go on to be followed as outpatients at CIMA.

Exclusion Criteria:

Patients who elect not to participate in the study.

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00224224


Locations
United States, New York
New York Presbyterian Hospital-Weill Medical College
New York, New York, United States, 10065
Sponsors and Collaborators
Weill Medical College of Cornell University
Investigators
Principal Investigator: Mary E Charlson, MD Weill Medical College of Cornell University
  More Information

Responsible Party: Mary E. Charlson, MD, Weill Cornell Medical College
ClinicalTrials.gov Identifier: NCT00224224     History of Changes
Other Study ID Numbers: 9510000400 (Formerly 1095-071)
First Submitted: September 20, 2005
First Posted: September 22, 2005
Last Update Posted: April 3, 2008
Last Verified: March 2008

Keywords provided by Weill Medical College of Cornell University:
Clinical performance
Continuity of care
Utilization of resources

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female